Видео ютуба по тегу Leukaemia Ph

Donald Small, M.D., Ph.D. - Pediatric Oncologist - Leukemia

Donald Small, M.D., Ph.D. - Pediatric Oncologist - Leukemia
Current management of Ph-positive ALL

Current management of Ph-positive ALL
Targeted therapy for elderly patients with Philadelphia-positive acute lymphocytic leukaemia

Targeted therapy for elderly patients with Philadelphia-positive acute lymphocytic leukaemia
Clinical approaches in Ph+ and Ph-like ALL

Clinical approaches in Ph+ and Ph-like ALL
The impact of age in Ph+ and Ph-like ALL

The impact of age in Ph+ and Ph-like ALL
IACH Journal Club: Dasatinib–Blinatumomab for Ph Positive Acute Lymphoblastic Leukemia in Adul

IACH Journal Club: Dasatinib–Blinatumomab for Ph Positive Acute Lymphoblastic Leukemia in Adul
Dr. Wetzler on Autologous Transplantation in Ph+ALL

Dr. Wetzler on Autologous Transplantation in Ph+ALL
MINHA ÁGUA ALCALINA PARA TRATAR A LEUCEMIA

MINHA ÁGUA ALCALINA PARA TRATAR A LEUCEMIA
Dasatinib-blinatumomab combination for the front-line treatment of adult Ph-positive ALL patients

Dasatinib-blinatumomab combination for the front-line treatment of adult Ph-positive ALL patients
Treatment approaches to Ph-like ALL: challenges and future outlooks

Treatment approaches to Ph-like ALL: challenges and future outlooks
John Pagel, M.D., Ph.D.

John Pagel, M.D., Ph.D.
Dasatinib vs imatinib for paediatric Ph+ALL

Dasatinib vs imatinib for paediatric Ph+ALL
The biology of Ph-like ALL and challenges in this disease subtype

The biology of Ph-like ALL and challenges in this disease subtype
Targeting TSLPR in Ph-like and Down syndrome-associated ALL

Targeting TSLPR in Ph-like and Down syndrome-associated ALL
Defining Ponatinib’s Role in Ph-Positive ALL

Defining Ponatinib’s Role in Ph-Positive ALL
Diagnostic strategies for Ph-like ALL

Diagnostic strategies for Ph-like ALL
Recent subtypes of ALL: Ph-like ALL and ETP ALL

Recent subtypes of ALL: Ph-like ALL and ETP ALL
Ph-like ALL: characteristics, outcomes and role of allo-HCT

Ph-like ALL: characteristics, outcomes and role of allo-HCT
Evolving therapy of Ph+ and Ph-like ALL

Evolving therapy of Ph+ and Ph-like ALL
EPCALM supports 1st PH Patients Congress | Adult Leukemia Foundation of the Philippines

EPCALM supports 1st PH Patients Congress | Adult Leukemia Foundation of the Philippines